Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara M Misof

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Calcified Tissue International|September 4, 2024
Bone Quality and Mineralization and Effects of Treatment in Osteogenesis ImperfectaBarbara M Misof, Nadja Fratzl-Zelman
Handbook of Experimental Pharmacology|August 9, 2020
Osteoporosis Therapeutics 2020Roland Kocijan, Klaus Klaushofer, Barbara M Misof
Wiener Medizinische Wochenschrift (1946)|July 26, 2015
Classification of osteogenesis imperfectaNadja Fratzl-Zelman, Barbara M Misof, Paul Roschger, et al.
Wiener Medizinische Wochenschrift (1946)|July 26, 2015
Bone mass and mineralization in osteogenesis imperfectaNadja Fratzl-Zelman, Barbara M Misof, Klaus Klaushofer, et al.
Current Osteoporosis Reports|October 28, 2023
Bone Material Properties in Bone Diseases Affecting ChildrenAdalbert Raimann, Barbara M Misof, Peter Fratzl, et al.
Current Osteoporosis Reports|February 11, 2016
Skeletal Implications of Chronic Obstructive Pulmonary DiseaseBarbara M Misof, Carolina A Moreira, Klaus Klaushofer, et al.
Journal of Musculoskeletal & Neuronal Interactions|June 13, 2019
Bone matrix mineralization and osteocyte lacunae characteristics in patients with chronic kidney disease - mineral bone disorder (CKD-MBD)Barbara M Misof, Stéphane Blouin, Paul Roschger, et al.
Bonekey Reports|February 25, 2015
Long-term safety of antiresorptive treatment: bone material, matrix and mineralization aspectsBarbara M Misof, Nadja Fratzl-Zelman, Eleftherios P Paschalis, et al.
International Journal of Molecular Sciences|October 30, 2020
No Role of Osteocytic Osteolysis in the Development and Recovery of the Bone Phenotype Induced by Severe Secondary Hyperparathyroidism in Vitamin D Receptor Deficient MiceBarbara M Misof, Stéphane Blouin, Jochen G Hofstaetter, et al.
Calcified Tissue International|March 4, 2008
Evidence that abnormal high bone mineralization in growing children with osteogenesis imperfecta is not associated with specific collagen mutationsPaul Roschger, Nadja Fratzl-Zelman, Barbara M Misof, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Calcified Tissue International|September 4, 2024
Bone Quality and Mineralization and Effects of Treatment in Osteogenesis ImperfectaBarbara M Misof, Nadja Fratzl-Zelman
Handbook of Experimental Pharmacology|August 9, 2020
Osteoporosis Therapeutics 2020Roland Kocijan, Klaus Klaushofer, Barbara M Misof
Wiener Medizinische Wochenschrift (1946)|July 26, 2015
Classification of osteogenesis imperfectaNadja Fratzl-Zelman, Barbara M Misof, Paul Roschger, et al.
Wiener Medizinische Wochenschrift (1946)|July 26, 2015
Bone mass and mineralization in osteogenesis imperfectaNadja Fratzl-Zelman, Barbara M Misof, Klaus Klaushofer, et al.
Current Osteoporosis Reports|October 28, 2023
Bone Material Properties in Bone Diseases Affecting ChildrenAdalbert Raimann, Barbara M Misof, Peter Fratzl, et al.
Current Osteoporosis Reports|February 11, 2016
Skeletal Implications of Chronic Obstructive Pulmonary DiseaseBarbara M Misof, Carolina A Moreira, Klaus Klaushofer, et al.
Journal of Musculoskeletal & Neuronal Interactions|June 13, 2019
Bone matrix mineralization and osteocyte lacunae characteristics in patients with chronic kidney disease - mineral bone disorder (CKD-MBD)Barbara M Misof, Stéphane Blouin, Paul Roschger, et al.
Bonekey Reports|February 25, 2015
Long-term safety of antiresorptive treatment: bone material, matrix and mineralization aspectsBarbara M Misof, Nadja Fratzl-Zelman, Eleftherios P Paschalis, et al.
International Journal of Molecular Sciences|October 30, 2020
No Role of Osteocytic Osteolysis in the Development and Recovery of the Bone Phenotype Induced by Severe Secondary Hyperparathyroidism in Vitamin D Receptor Deficient MiceBarbara M Misof, Stéphane Blouin, Jochen G Hofstaetter, et al.
Calcified Tissue International|March 4, 2008
Evidence that abnormal high bone mineralization in growing children with osteogenesis imperfecta is not associated with specific collagen mutationsPaul Roschger, Nadja Fratzl-Zelman, Barbara M Misof, et al.
Pageof 5